Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CONQUER Cancer Study: To Collect Blood Samples From Cancer and Non-cancer Participants for Development and Validation of the 'OncoSweep Cancer Spotlight and Spectrum Product Line

NCT06261294 is registered in ClinicalTrials.gov with Pharus Taiwan, Inc. as lead sponsor.

NCT NCT06261294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06261294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CONQUER Cancer Study: To Collect Blood Samples From Cancer and Non-cancer Participants for Development and Validation of the 'OncoSweep Cancer Spotlight and Spectrum Product Line
Lead sponsor
Pharus Taiwan, Inc.
Phase
Observational
Overall status
Completed
Start date
May 29, 2023
Completion date
May 7, 2025
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer